• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    IHS Markit Ltd. filed SEC Form 8-K: Leadership Update

    2/2/22 4:17:26 PM ET
    $INFO
    Get the next $INFO alert in real time by email
    info-20220201
    0001598014false00015980142022-02-012022-02-01

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    FORM 8-K


    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 1, 2022
    ______________________

    IHS MARKIT LTD.
    (Exact name of registrant as specified in its charter)
    Bermuda001-3649598-1166311
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

    4th Floor, Ropemaker Place
    25 Ropemaker Street
    London, England
    EC2Y 9LY
    (Address of principal executive offices and zip code)

    +44 20 7260 2000
    (Registrant's telephone number, including area code)

    Former name or former address, if changed since last report: Not Applicable
    ______________________


    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Shares, $0.01 par value per shareINFONew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o







    ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On January 29, 2022, the Human Resources Committee (the “Committee”) of the Board of Directors of IHS Markit Ltd. (the “Company”) approved a special cash award to Adam Kansler in the amount of $500,000 to be paid no later than February 28, 2022, in recognition of his exceptional performance during the integration planning process of the Company’s pending merger with S&P Global Inc.









    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    IHS MARKIT LTD.
    Date: February 2, 2022By:/s/ Sari Granat
    Sari Granat
    Executive Vice President, Chief Administrative Officer, and General Counsel


    Get the next $INFO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INFO

    DatePrice TargetRatingAnalyst
    2/9/2022$140.00 → $133.00Overweight
    Morgan Stanley
    1/24/2022$142.00 → $118.00Market Perform
    BMO Capital
    1/24/2022$149.00 → $140.00Overweight
    Morgan Stanley
    1/5/2022$144.00 → $149.00Overweight
    Morgan Stanley
    10/27/2021$137.00 → $144.00Overweight
    Morgan Stanley
    9/29/2021$141.00 → $137.00Overweight
    Morgan Stanley
    9/23/2021$139.00 → $141.00Overweight
    Morgan Stanley
    7/30/2021$135.00 → $139.00Overweight
    Morgan Stanley
    More analyst ratings